"Astra vaccine we fit, is there no risk of side effects?"

<Anchor>

Medical reporter Cho Dong-chan is here.

[Cho Dong-chan/medical journalist (specialist): To start with the conclusion, you don't have to worry too much.

Of the 23,000 clinical participants, three had serious neurological side effects such as myelitis. One is a vaccine, one is a fake drug, and one is a participant who is not allowed to disclose whether they have received a vaccine or a fake drug.

All three have recovered or are recovering, and the European and US Food and Drug Administration concluded that the vaccine relevance is not clearly visible.

Since we have secured 10 million AstraZeneca vaccines and 4 million Janssen vaccines using a live virus, there are theoretically possible side effects, so we must pay close attention, but it can be said that it is safe from what has been released so far.]

[Cho Dong-chan/medical reporter (specialist): It was a popular media report in the United States, so it was a big wave, but first of all, AstraZeneca denied, and if the US FDA prolonged reporting side effects, the clinical trial was canceled altogether.

But I'm doing it in America right now.

I don't think it's true, only Pfizer and AstraZeneca have been transparently disclosed as the final results of the phase 3 clinical trial.

Pfizer said yesterday (8th) through the US FDA that AstraZeneca released its results yesterday through the world's three largest medical journals, Lancet, but it is different that it has been verified by experts, unlike those that were published unilaterally through the media.]

[Dong-Chan Jo/Medicine reporter (specialist): Even if the approval in the US is delayed, if it is approved within this year in Europe and the UK, the timing of introduction in Korea will not be delayed next year.]

[Cho Dong-chan/medical reporter (specialist): Pfizer said it would be difficult to supply additional supplies until next June in the US, too.

It seems difficult for Korea to receive Pfizer vaccine next year.

However, the variable is when the number of outsourced production facilities increases, but the situation may be different if related facilities in China are mass-producing.]

[Cho Dong-chan/medical journalist (specialist): This is two times every 21 days, but if the low dose and high dose were correct, the effectiveness was 90%, and the high dose and high dose came out as effective 62%. However, the high-efficiency low-dose and high-dose were 18-55 years old Only age has done clinical trials.

So now, clinical trials are underway for people over 65 years old, and domestic experts are still expecting that it will be effective for the elderly, but I have to watch it.

However, since the clinical test is not available for women under 18 years of age and pregnant women, it cannot be met, and those with severe allergies should be careful.]

▶ Side effects of Pfizer vaccine'facial paralysis'…

US "Judging as scheduled"